First Momentum Ventures4 min read
Swiss startup Atlas Bio secures $12.5M to tackle drug development’s 70% failure rate and move beyond animal testing
Swiss tech-bio firm Atlas Bio today launched from stealth with a $10 million Seed round led by Creandum, alongside a previously unannounced pre-Seed round led by First Momentum Ventures and LEA Partne...
By Cate LawrenceTech.eu

Read the full story
Originally published by Tech.eu on Oct 27, 2026.
Comments
Sign in to join the discussion.